Product References
Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer.
Pharmaceuticals (Basel, Switzerland)
de Muijnck C,van Gorkom Y,van Duijvenvoorde M,Eghtesadi M,Dekker-Ensink G,Bhairosingh SS,Affinito A,Kuppen PJK,Vahrmeijer AL,Sier CFM
37-1800 was used in Immunohistochemistry to prove that EphB4 is a promising candidate for targeted image-guided surgery of breast cancer, especially for Her2 negative cases.
Thu Jul 30 00:00:00 EDT 2020
Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer.
Pharmaceuticals (Basel, Switzerland)
de Muijnck C,van Gorkom Y,van Duijvenvoorde M,Eghtesadi M,Dekker-Ensink G,Bhairosingh SS,Affinito A,Kuppen PJK,Vahrmeijer AL,Sier CFM
37-1800 was used in Immunohistochemistry to prove that EphB4 is a promising candidate for targeted image-guided surgery of breast cancer, especially for Her2 negative cases.
Thu Jul 30 00:00:00 EDT 2020
Human blood vessel organoids as a model of diabetic vasculopathy.
Nature
Wimmer RA,Leopoldi A,Aichinger M,Wick N,Hantusch B,Novatchkova M,Taubenschmid J,Hämmerle M,Esk C,Bagley JA,Lindenhofer D,Chen G,Boehm M,Agu CA,Yang F,Fu B,Zuber J,Knoblich JA,Kerjaschki D,Penninger JM
37-1800 was used in Immunocytochemistry-immunoflourescence to suggest that blood vessel organoids derived from human stem cells faithfully recapitulate the structure and function of human blood vessels and are a suitable model for diabetic vasculopathy.
Tue Jan 01 00:00:00 EST 2019
Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.
International journal of oncology
Magic Z,Sandström J,Perez-Tenorio G
Published figure using EphB4 monoclonal antibody (Product # 37-1800) in Western Blot
Sun Dec 01 00:00:00 EST 2019
Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.
International journal of molecular sciences
Stammes MA,Prevoo HA,Ter Horst MC,Groot SA,Van de Velde CJ,Chan AB,de Geus-Oei LF,Kuppen PJ,Vahrmeijer AL,Pasquale EB,Sier CF
371800 was used in immunohistochemistry - paraffin section to examine if EphA2 and EphB4 proteins are suitable targets for image-guided oncologic surgery of colorectal cancer
Fri Feb 03 00:00:00 EST 2017
Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.
International journal of molecular sciences
Stammes MA,Prevoo HA,Ter Horst MC,Groot SA,Van de Velde CJ,Chan AB,de Geus-Oei LF,Kuppen PJ,Vahrmeijer AL,Pasquale EB,Sier CF
371800 was used in immunohistochemistry - paraffin section to examine if EphA2 and EphB4 proteins are suitable targets for image-guided oncologic surgery of colorectal cancer
Fri Feb 03 00:00:00 EST 2017
Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.
International journal of molecular sciences
Stammes MA,Prevoo HA,Ter Horst MC,Groot SA,Van de Velde CJ,Chan AB,de Geus-Oei LF,Kuppen PJ,Vahrmeijer AL,Pasquale EB,Sier CF
371800 was used in immunohistochemistry - paraffin section to examine if EphA2 and EphB4 proteins are suitable targets for image-guided oncologic surgery of colorectal cancer
Fri Feb 03 00:00:00 EST 2017
Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.
International journal of molecular sciences
Stammes MA,Prevoo HA,Ter Horst MC,Groot SA,Van de Velde CJ,Chan AB,de Geus-Oei LF,Kuppen PJ,Vahrmeijer AL,Pasquale EB,Sier CF
371800 was used in immunohistochemistry - paraffin section to examine if EphA2 and EphB4 proteins are suitable targets for image-guided oncologic surgery of colorectal cancer
Fri Feb 03 00:00:00 EST 2017
Erythropoietin Stimulates Tumor Growth via EphB4.
Cancer cell
Pradeep S,Huang J,Mora EM,Nick AM,Cho MS,Wu SY,Noh K,Pecot CV,Rupaimoole R,Stein MA,Brock S,Wen Y,Xiong C,Gharpure K,Hansen JM,Nagaraja AS,Previs RA,Vivas-Mejia P,Han HD,Hu W,Mangala LS,Zand B,Stagg LJ,Ladbury JE,Ozpolat B,Alpay SN,Nishimura M,Stone RL,Matsuo K,Armaiz-Peña GN,Dalton HJ,Danes C,Goodman B,Rodriguez-Aguayo C,Kruger C,Schneider A,Haghpeykar S,Jaladurgam P,Hung MC,Coleman RL,Liu J,Li C,Urbauer D,Lopez-Berestein G,Jackson DB,Sood AK
Published figure using EphB4 monoclonal antibody (Product # 37-1800) in Immunohistochemistry
Mon Nov 09 00:00:00 EST 2015
YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.
American journal of cancer research
Dubois F,Leroy C,Simon V,Benistant C,Roche S
37-1800 was used in immunoprecipitation to elucidate how YES contributes to colorectal cancer progression
Thu Aug 13 00:00:00 EDT 2015
Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.
Medical oncology (Northwood, London, England)
Guijarro-Muñoz I,Sánchez A,Martínez-Martínez E,García JM,Salas C,Provencio M,Alvarez-Vallina L,Sanz L
37-1800 was used in immunohistochemistry (paraffin) to investigate the prognostic value of EPHB4 in colorectal cancer therapy.
Fri Oct 25 00:00:00 EDT 2013
EPHB4 and survival of colorectal cancer patients.
Cancer research
Davalos V,Dopeso H,Castaño J,Wilson AJ,Vilardell F,Romero-Gimenez J,Espín E,Armengol M,Capella G,Mariadason JM,Aaltonen LA,Schwartz S,Arango D
37-1800 was used in immunohistochemistry - paraffin section and western blot to study the role of EPHB4 in colorectal cancer and determine its value as a prognostic marker
Fri Sep 15 00:00:00 EDT 2006
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
The Journal of biological chemistry
Koolpe M,Burgess R,Dail M,Pasquale EB
Fri Apr 29 00:00:00 EDT 2005
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
The Journal of biological chemistry
Koolpe M,Burgess R,Dail M,Pasquale EB
Fri Apr 29 00:00:00 EDT 2005
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
The Journal of biological chemistry
Koolpe M,Burgess R,Dail M,Pasquale EB
Fri Apr 29 00:00:00 EDT 2005
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
The Journal of biological chemistry
Koolpe M,Burgess R,Dail M,Pasquale EB
Fri Apr 29 00:00:00 EDT 2005